FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

41314111000001107: Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Dec 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2505661000001118 Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2505671000001111 Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Azacitidine 200mg tablets true Inferred relationship Existential restriction modifier
Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Onureg true Inferred relationship Existential restriction modifier
Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Azacitidine true Inferred relationship Existential restriction modifier
Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 tablet Has AMP True Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start